1.27 USD
▼-0.08-9.93%
盘后 1.51 +7.09%
2026-08-03
市值
$29.96M
市盈率
—
EPS
-0.39
股息率
—
52 周区间
0.55 – 10.00
成交量
108.19K
Beta
0.75
目标价
—
52W 低 0.5552W 高 10.00
价格走势
公司简介
Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/m...